3.4 Views on MDTB-related issues
Likert-scale responses to 28 of 30 (93.3%) questions did not differ between oncologist and surgeon respondents (p >0.05). Significantly different responses were noted to 2 questions on patients that should be discussed at MDTBs (“All new pediatric cancer patients should be discussed in detail”, and “Patient preferences and social circumstances should always be commented on”) (p =0.015 and 0.009, respectively). Details of responses are summarized in Fig 3 and Supplemental Table S3.